APEX INVESTMENT Harvard Case Solution & Analysis

APEX INVESTMENT The Case Solution

Question 5

The total enterprise value of Access-line is 699.62. We have taken the growth rate of 5%and the terminal value is 624.6514. We have taken the cost of capital for this calculation from assumptions table i.e. 14.50%. The outstanding shares are taken from the Optimal warrant Policy in order to evaluate the minimum value generation of the cash flows. The outstanding shares was 13001256 and share price accordingly was $53.81further refer appendix 5.

.Question 6

The deal is beneficial to Apex Company, as the Access-line Company is expected to achieve a huge growth in its sales revenue as given in the cash flow projections. Secondly, the company’s future prospects are lucrative for Apex. The estimated share value resulted in paying a premium towards the Access-line, which seems reasonable looking at the future profitability and growth potential of the company.

Question 7

To manage the firm Apex would be given the voting rights and also evaluating the accuracy of accounting and internal audits. Apex would be given the right give their opinion in important decision making. Apex would be on board while making decisions for future. Apex would be involved while making decision regarding capital investments and capital structure.

Appendices

Appendix 1

Valuation- Warrants are Not exercised
Series A  
Price $7  
  Shares in # Market Cap Percentage
Existing Investors (Common Class A&B) 7931060 $55,517,420 78.72%
New Investors  (Series A preferred) 0 $0 0.00%
Management & Employees Shares 2143846 $15,006,922 21.28%
Total 10074906 $70,524,342 100.00%
   
Series B  
Price $8  
  Shares in # Market Cap Percentage
Existing Investors (Common Class A&B) 8086099 $64,688,792 62.74%
New Investors  (Series A preferred) 2220726 $17,765,808 17.23%
New Investors  (Series B preferred) 0 $0 0.00%
Management & Employees Shares 2582047 $20,656,376 20.03%
Total 12888872 $103,110,976 100.00%

Appendix 2

Valuation- Warrants are  exercised
Series A  
Price $7  
  Shares in # Market Cap Percentage
Existing Investors (Common Class A&B) 7931060 $55,517,420 64.50%
New Investors  (Series A preferred) 2220726 $15,545,082 18.06%
Management & Employees Shares 2143846 $15,006,922 17.44%
Total 12295632 $86,069,424 100.00%
   
Series B  
Price $8  
  Shares in # Market Cap Percentage
Existing Investors (Common Class A&B) 8086099 $64,688,792 54.31%
New Investors  (Series A preferred) 2220726 $17,765,808 14.92%
New Investors  (Series B preferred) 2000000 $16,000,000 13.43%
Management & Employees Shares 2582047 $20,656,376 17.34%
Total 14888872 $119,110,976 100.00%

Appendix 3

Exit Proceeds (if warrants exercised)
New Investors  (Series A preferred) $15,545,082
New Investors  (Series A preferred) $17,765,808
New Investors  (Series B preferred) $16,000,000
Total Exit Proceeds $49,310,890

Appendix 4

Optimal Warrant Exercise Policy - Exit Proceeds
Series A  
Price $7  
  Shares in # Market Cap Percentage
Existing Investors (Common Class A&B) 7931060 $55,517,420 63.07%
New Investors  (Series A preferred) 2500000 $17,500,000 19.88%
Management & Employees Shares 2143846 $15,006,922 17.05%
Total 12574906 $88,024,342 100.00%
Series B  
Price $8  
  Shares in # Market Cap Percentage
Existing Investors (Common Class A&B) 8086099 $64,688,792 62.19%
New Investors  (Series A preferred) 333110 $2,664,880 2.56%
New Investors  (Series B preferred) 2000000 $16,000,000 15.38%
Management & Employees Shares 2582047 $20,656,376 19.86%
Total 13001256 104010048 100.00%
   
Exit Proceeds  
New Investors  (Series A preferred) $17,500,000  
New Investors  (Series A preferred) $2,664,880  
New Investors  (Series B preferred) $16,000,000  
Total $36,164,880    

................

This is just a sample partial case solution. Please place the order on the website to order your own originally done case solution.

 

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.